Literature DB >> 35373104

Should Oral Anticoagulation Be Used in ESKD Patients on Hemodialysis with Atrial Fibrillation?: CON.

Benjamin Lidgard1, Nisha Bansal1.   

Abstract

Entities:  

Keywords:  ESKD; anticoagulants; atrial fibrillation; blood coagulation; dialysis; hemodialysis

Mesh：

Substances：

Year:  2021        PMID： 35373104      PMCID： PMC8786128          DOI： 10.34067/KID.0006602020

Source DB:  PubMed          Journal:  Kidney360        ISSN： 2641-7650


× No keyword cloud information.
  10 in total

1.  Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States.

Authors:  Konstantinos C Siontis; Xiaosong Zhang; Ashley Eckard; Nicole Bhave; Douglas E Schaubel; Kevin He; Anca Tilea; Austin G Stack; Rajesh Balkrishnan; Xiaoxi Yao; Peter A Noseworthy; Nilay D Shah; Rajiv Saran; Brahmajee K Nallamothu
Journal:  Circulation       Date:  2018-10-09       Impact factor: 29.690

Review 2.  Meta-Analysis of Anticoagulation Use, Stroke, Thromboembolism, Bleeding, and Mortality in Patients With Atrial Fibrillation on Dialysis.

Authors:  Christopher X Wong; Ayodele Odutayo; Connor A Emdin; Ned J Kinnear; Michelle T Sun
Journal:  Am J Cardiol       Date:  2016-04-13       Impact factor: 2.778

3.  Stroke and bleeding in atrial fibrillation with chronic kidney disease.

Authors:  Jonas Bjerring Olesen; Gregory Y H Lip; Anne-Lise Kamper; Kristine Hommel; Lars Køber; Deirdre A Lane; Jesper Lindhardsen; Gunnar Hilmar Gislason; Christian Torp-Pedersen
Journal:  N Engl J Med       Date:  2012-08-16       Impact factor: 91.245

4.  A systematic review of direct oral anticoagulant use in chronic kidney disease and dialysis patients with atrial fibrillation.

Authors:  Jordanne Feldberg; Param Patel; Ashley Farrell; Sylvia Sivarajahkumar; Karen Cameron; Jennifer Ma; Marisa Battistella
Journal:  Nephrol Dial Transplant       Date:  2019-02-01       Impact factor: 5.992

5.  Apixaban versus warfarin in patients with atrial fibrillation.

Authors:  Christopher B Granger; John H Alexander; John J V McMurray; Renato D Lopes; Elaine M Hylek; Michael Hanna; Hussein R Al-Khalidi; Jack Ansell; Dan Atar; Alvaro Avezum; M Cecilia Bahit; Rafael Diaz; J Donald Easton; Justin A Ezekowitz; Greg Flaker; David Garcia; Margarida Geraldes; Bernard J Gersh; Sergey Golitsyn; Shinya Goto; Antonio G Hermosillo; Stefan H Hohnloser; John Horowitz; Puneet Mohan; Petr Jansky; Basil S Lewis; Jose Luis Lopez-Sendon; Prem Pais; Alexander Parkhomenko; Freek W A Verheugt; Jun Zhu; Lars Wallentin
Journal:  N Engl J Med       Date:  2011-08-27       Impact factor: 91.245

6.  Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Severe Kidney Disease or Undergoing Hemodialysis.

Authors:  Craig I Coleman; Reinhold Kreutz; Nitesh A Sood; Thomas J Bunz; Daniel Eriksson; Anna-Katharina Meinecke; William L Baker
Journal:  Am J Med       Date:  2019-05-02       Impact factor: 4.965

7.  Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients.

Authors:  Yi-Wen Chiu; Isaac Teitelbaum; Madhukar Misra; Essel Marie de Leon; Tochi Adzize; Rajnish Mehrotra
Journal:  Clin J Am Soc Nephrol       Date:  2009-05-07       Impact factor: 8.237

8.  Fatal Dialysis Vascular Access Hemorrhage.

Authors:  Matthew D Jose; Mark R Marshall; Gail Read; Nicole Lioufas; Jon Ling; Paul Snelling; Kevan R Polkinghorne
Journal:  Am J Kidney Dis       Date:  2017-06-30       Impact factor: 8.860

Review 9.  Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: a systematic review and meta-analysis.

Authors:  Jingwen Tan; Shuiqing Liu; Jodi B Segal; G Caleb Alexander; Mara McAdams-DeMarco
Journal:  BMC Nephrol       Date:  2016-10-21       Impact factor: 2.388

10.  Association Between Use of Warfarin for Atrial Fibrillation and Outcomes Among Patients With End-Stage Renal Disease: A Systematic Review and Meta-analysis.

Authors:  Mandeep S Randhawa; Rohanlal Vishwanath; Manoj P Rai; Ling Wang; Amritpal K Randhawa; George Abela; Gaurav Dhar
Journal:  JAMA Netw Open       Date:  2020-04-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.